Cargando…

Serum Lactate Dehydrogenase Levels as a Predictive Marker of Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer

Objective: Clinical laboratory test data obtained prior to treatments were previously analyzed from the standpoint of susceptibility to hypersensitivity reactions in patients treated with the platimun anticancer agent, oxaliplatin (L-OHP). In the present study, the time course from the first to last...

Descripción completa

Detalles Bibliográficos
Autores principales:	Seki, Kyoko, Tsuduki, Yasuo, Ioroi, Takeshi, Yamane, Michiko, Yamauchi, Hiroko, Shiraishi, Yukinari, Ogawa, Tadaaki, Nakata, Izumi, Nishiguchi, Kohshi, Matsubayashi, Teruhisa, Takakubo, Yoshihide, Yamamori, Motohiro, Kuwahara, Akiko, Okamura, Noboru, Sakaeda, Toshiyuki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2014
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4003551/ https://www.ncbi.nlm.nih.gov/pubmed/24782655 http://dx.doi.org/10.7150/ijms.7643

Ejemplares similares

Risk Factors for Oxaliplatin-Induced Hypersensitivity Reactions in Japanese Patients with Advanced Colorectal Cancer
por: Seki, Kyoko, et al.
Publicado: (2011)

VEGF -634C/G Genotype is Predictive of Long-term Survival after Treatment with a Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma
por: Tamura, Takao, et al.
Publicado: (2012)

Hypersensitivity reactions to anticancer agents: Data mining of the public version of the FDA adverse event reporting system, AERS
por: Kadoyama, Kaori, et al.
Publicado: (2011)

Effects of plasma concentrations of 5-fluorouracil on long-term survival after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
por: Kuwahara, Akiko, et al.
Publicado: (2011)

Platinum Agent-Induced Hypersensitivity Reactions: Data Mining of the Public Version of the FDA Adverse Event Reporting System, AERS
por: Sakaeda, Toshiyuki, et al.
Publicado: (2011)

Effects of Bolus Injection of 5-Fluorouracil on Steady-State Plasma Concentrations of 5-Fluorouracil in Japanese Patients with Advanced Colorectal Cancer
por: Tamura, Takao, et al.
Publicado: (2011)

Replacement of cisplatin with nedaplatin in a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
por: Kuwahara, Akiko, et al.
Publicado: (2009)

THRB Genetic Polymorphisms Can Predict Severe Myelotoxicity after Definitive Chemoradiotherapy in Patients with Esophageal Squamous Cell Carcinoma
por: Miki, Ikuya, et al.
Publicado: (2012)

Genetic Polymorphisms in SLC23A2 as Predictive Biomarkers of Severe Acute Toxicities after Treatment with a Definitive 5-Fluorouracil/Cisplatin-Based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma
por: Minegaki, Tetsuya, et al.
Publicado: (2014)

TNFRSF1B A1466G genotype is predictive of clinical efficacy after treatment with a definitive 5-fluorouracil/cisplatin-based chemoradiotherapy in Japanese patients with esophageal squamous cell carcinoma
por: Kuwahara, Akiko, et al.
Publicado: (2010)

Effect of dose-escalation of 5-fluorouracil on circadian variability of its pharmacokinetics in Japanese patients with Stage III/IVa esophageal squamous cell carcinoma
por: Kuwahara, Akiko, et al.
Publicado: (2010)

TNF-α -857C>T Genotype is Predictive of Clinical Response after Treatment with Definitive 5-Fluorouracil/cisplatin-based Chemoradiotherapy in Japanese Patients with Esophageal Squamous Cell Carcinoma
por: Omatsu, Hideaki, et al.
Publicado: (2013)

VEGF T-1498C polymorphism, a predictive marker of differentiation of colorectal adenocarcinomas in Japanese
por: Yamamori, Motohiro, et al.
Publicado: (2008)

Lower Body Mass Index is a Risk Factor for In-Hospital Mortality of Elderly Japanese Patients Treated with Ampicillin/sulbactam
por: Miura, Makoto, et al.
Publicado: (2016)

The Novel Anticancer Drug KRN5500 Interacts with, but is Hardly Transported by, Human P‐Glycoprotein
por: Takara, Kohji, et al.
Publicado: (2000)

In vitro and in vivo cytotoxicity of troglitazone in pancreatic cancer
por: Fujita, Megumi, et al.
Publicado: (2017)

Hypersensitivity reactions related to oxaliplatin (OHP)
por: Brandi, G, et al.
Publicado: (2003)

Hypersensitivity to oxaliplatin: clinical features and risk factors
por: Parel, Marie, et al.
Publicado: (2014)

Serum cystatin C levels to predict serum concentration of digoxin in Japanese patients
por: Nakamura, Tsutomu, et al.
Publicado: (2006)

Differentiating between Laryngopharyngeal Dysesthesia and Hypersensitivity Reactions to Oxaliplatin and Addressing Dyspnea: 2 Case Reports
por: Kawaguchi, Fumitaka, et al.
Publicado: (2023)

Granulomatous interstitial nephritis associated with atypical drug-induced hypersensitivity syndrome induced by carbamazepine
por: Eguchi, Eriko, et al.
Publicado: (2011)

Clinical Analysis of Hypersensitivity Reactions to Oxaliplatin Among Colorectal Cancer Patients
por: Shen, Yuping, et al.
Publicado: (2018)

Oxaliplatin-induced cold hypersensitivity is due to remodelling of ion channel expression in nociceptors
por: Descoeur, Juliette, et al.
Publicado: (2011)

Meta-analysis of risk factors associated with oxaliplatin hypersensitivity reactions in cancer patients
por: Zhu, Linhui, et al.
Publicado: (2021)

Oxaliplatin-Related Hypersensitivity Reactions: A Single Institution Series and Literature Review
por: Barbin, Francesca, et al.
Publicado: (2022)

Cytotoxicity of 15-Deoxy-Δ(12,14)-prostaglandin J(2) through PPARγ-independent Pathway and the Involvement of the JNK and Akt Pathway in Renal Cell Carcinoma
por: Fujita, Megumi, et al.
Publicado: (2012)

Oxaliplatin-induced neurotoxicity involves TRPM8 in the mechanism of acute hypersensitivity to cold sensation
por: Kono, Toru, et al.
Publicado: (2012)

Brain activity changes in a macaque model of oxaliplatin-induced neuropathic cold hypersensitivity
por: Nagasaka, Kazuaki, et al.
Publicado: (2017)

Dipyridamole Combined with Tumor Necrosis Factor‐α Enhances Inhibition of Proliferation in Human Tumor Cell Lines
por: Suzuki, Nobuo, et al.
Publicado: (1995)

A Polyamine-Deficient Diet Prevents Oxaliplatin-Induced Acute Cold and Mechanical Hypersensitivity in Rats
por: Ferrier, Jérémy, et al.
Publicado: (2013)

Acute cold hypersensitivity characteristically induced by oxaliplatin is caused by the enhanced responsiveness of TRPA1 in mice
por: Zhao, Meng, et al.
Publicado: (2012)

The G2A receptor (GPR132) contributes to oxaliplatin-induced mechanical pain hypersensitivity
por: Hohmann, Stephan W., et al.
Publicado: (2017)

Pharmacological comparison of a nonhuman primate and a rat model of oxaliplatin‐induced neuropathic cold hypersensitivity
por: Shidahara, Yuka, et al.
Publicado: (2016)

Phytochemicals of Cinnamomi Cortex: Cinnamic Acid, but not Cinnamaldehyde, Attenuates Oxaliplatin-Induced Cold and Mechanical Hypersensitivity in Rats
por: Chae, Hyeon Kyeong, et al.
Publicado: (2019)

Incidence of oxaliplatin hypersensitivity reaction among colorectal cancer patients: A 5-year retrospective study
por: Palapinyo, Sirinoot, et al.
Publicado: (2022)

Hypersensitivity reaction and acute immune-mediated thrombocytopenia from oxaliplatin: two case reports and a review of the literature
por: Bautista, Marnelli A, et al.
Publicado: (2010)

Correction: Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

Proteomic Identification of Protein Targets for 15-Deoxy-Δ(12,14)-Prostaglandin J(2) in Neuronal Plasma Membrane
por: Yamamoto, Yasuhiro, et al.
Publicado: (2011)

Factors affecting the sensitivity of human-derived esophageal carcinoma cell lines to 5-fluorouracil and cisplatin
por: MINEGAKI, TETSUYA, et al.
Publicado: (2013)

Minoxidil-induced lung disease, masquerading as hypersensitivity pneumonitis
por: Takekosh, Daisuke, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t3a7l5ih6feqbtpa9of3kh3itr